These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 323966)

  • 21. [Results with the sustained-action neuroleptic fluspirilene on chronic schizophrenic patients undergoing occupational therapy].
    Gálfi B; Benson K; Grynaeus T
    Int Pharmacopsychiatry; 1973; 8(1):37-59. PubMed ID: 4595192
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical experiences in an open and a double-blind trial.
    Pöldinger W
    Acta Psychiatr Belg; 1978; 78(1):96-101. PubMed ID: 347884
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Experiences with the depot-neuroleptic agent Dapotum D].
    Teutsch H; Boissi KW
    Med Welt; 1974 Nov; 25(48):2027-32. PubMed ID: 4459664
    [No Abstract]   [Full Text] [Related]  

  • 24. [Report on the clinical test of the long-term neuroleptic agent penfluridol].
    Glatzel J
    Med Welt; 1973 Dec; 24(51):2044-6. PubMed ID: 4204355
    [No Abstract]   [Full Text] [Related]  

  • 25. Computerized EEG: predictor of outcome in schizophrenia.
    Itil TM; Marasa J; Saletu B; Davis S; Mucciardi AN
    J Nerv Ment Dis; 1975 Mar; 160(3):118-203. PubMed ID: 1090708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subnormal CSF levels of neurotensin in a subgroup of schizophrenic patients: normalization after neuroleptic treatment.
    Widerlöv E; Lindström LH; Besev G; Manberg PJ; Nemeroff CB; Breese GR; Kizer JS; Prange AJ
    Am J Psychiatry; 1982 Sep; 139(9):1122-6. PubMed ID: 6126127
    [No Abstract]   [Full Text] [Related]  

  • 27. [Pipothiazine (piportil) in the treatment of various forms of schizophrenia].
    Matkowski K; Sep-Kowalikowa B
    Psychiatr Pol; 1979; 13(4):421-3. PubMed ID: 42095
    [No Abstract]   [Full Text] [Related]  

  • 28. Long-term depot neuroleptic treatment with perphenazine decanoate. I. Efficacy and side effects in a 12 month study of 42 drug monitored psychotic patients.
    Knudsen P; Hansen LB; Højholdt K; Larsen NE
    Acta Psychiatr Scand Suppl; 1985; 322():29-40. PubMed ID: 3907279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A new substituted benzamide with neuroleptic effects: lin 14 18 or sultopride].
    Dufour H; Castelli J; Luccioni H; Scotto JC; Sutter JM
    Encephale; 1975; 1(1):15-8. PubMed ID: 1093843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Complex use of phenazepam, lithium and haloperidol in the treatment of several forms of schizophrenia].
    Mosketi KV; Mokhovikov AN; Aksent'ev SB; Goĭkhberg IG; Kryzhanovskiĭ GN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(4):589-96. PubMed ID: 6730829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Opiran, anxiety and psychosis; apropos of the therapeutic trial of a new incisive neuroleptic drug].
    Giudicelli S
    Ann Med Psychol (Paris); 1972 Mar; 1(3):407-13. PubMed ID: 5066197
    [No Abstract]   [Full Text] [Related]  

  • 32. Three long-acting neuroleptic drugs. Comparative study.
    de Francisco CP
    Int J Neurol; 1975; 10(1-4):41-5. PubMed ID: 1181318
    [No Abstract]   [Full Text] [Related]  

  • 33. Haloperidol decanoate as a replacement for maintenance therapy with intramuscular fluphenazine decanoate in schizophrenia and other chronic psychoses.
    Roose K
    Acta Psychiatr Belg; 1982; 82(2):216-23. PubMed ID: 7180558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Long-term treatment of schizophrenic patients with leponex (clozapine)].
    Panteleeva GP; Tsutsul'kovskaia MIa; Mazurskiĭ MB; Danilenko IuM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1978; 78(8):1247-56. PubMed ID: 696118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Differential neuroleptic treatment of schizophrenic psychoses in puerperium: advantages of the atypical neuroleptic clozapine].
    Weller M; Kornhuber J
    Nervenarzt; 1992 Jul; 63(7):440-1. PubMed ID: 1501722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The depot compounds moditen (fluphenazine) and IMAP (fluspirilene) in clinical practice.
    Faltus F
    Act Nerv Super (Praha); 1974 Aug; 16(3):167-8. PubMed ID: 4607824
    [No Abstract]   [Full Text] [Related]  

  • 37. [Trial at the guidance center of ixelles of a major neuroleptic drug: anatensol decanoate].
    Berliner J
    Acta Psychiatr Belg; 1974 May; 74(3):305-16. PubMed ID: 4455024
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effects of gamma-vinyl GABA per os in 5 cases of hebephreno-catatonic schizophrenia].
    Lambert PA; Chabannnes JP; Cantiniaux P; Schechter PJ; Tell GP
    Encephale; 1983; 9(2):145-9. PubMed ID: 6641616
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical study on five depot neuroleptics. Comparison of effective profiles of fluphenazinedecanoate, fluspirilene, penfluridol, perphenazine-enanthate and pipothiazinepalmitate].
    Angst J; Woggon B
    Arzneimittelforschung; 1975 Feb; 25(2):267-70. PubMed ID: 1091272
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Haloperidol decanoate: results of a 6-month open trial in paranoid schizophrenia].
    Pérez C; Stier Rosner SE
    Acta Psiquiatr Psicol Am Lat; 1989; 35(3-4):111-5. PubMed ID: 2576990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.